XERS
Companies
NASDAQ
Xeris Biopharma Holdings Inc.
Health Care
$4.58
+$1.19 (+35.10%)
Price Chart
Overview
About XERS
xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.
Market Cap
$345.4M
Volume
18.3M
Avg. Volume
18.1M
P/E Ratio
-18.772728
Dividend Yield
0.00%
Employees
368.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.16
Moderate Correlation
Volatility
High (0.53)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, XERS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$345.4M
Volume18.3M
P/E Ratio-18.77
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025